---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000949"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:56:08.259518+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# The Oncology Institute receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days

## Summary
- Nasdaq notice on June 20, 2024 for non-compliance with minimum bid price rule 5550(a)(2).
- Common stock bid price below $1.00 per share for 30 consecutive business days.
- 180-day compliance period ends December 17, 2024; may get additional 180 days if eligible.
- To regain compliance, bid price must close at $1.00+ for 10 consecutive business days.
- Company will consider options including a reverse stock split, subject to stockholder approval.

## SEC filing metadata
- accession: 0001079973-24-000949
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997324000949/0001079973-24-000949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997324000949/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000949
- JSON: https://secwatch.observer/filing/0001079973-24-000949.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000949.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
